Neuren Pharmaceuticals Limited (NEU.AX)
| Previous Close | 13.11 |
| Open | 13.20 |
| Bid | 13.10 x 0 |
| Ask | 13.18 x 0 |
| Day's Range | 13.07 - 13.44 |
| 52 Week Range | 10.02 - 25.95 |
| Volume | |
| Avg. Volume | 505,072 |
| Market Cap | 1.708B |
| Beta (5Y Monthly) | 2.13 |
| PE Ratio (TTM) | 13.97 |
| EPS (TTM) | 0.94 |
| Earnings Date | Aug 27, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 28.68 |
Simply Wall St.3 Undervalued Small Caps In Australia With Insider Buying
Over the last 7 days, the Australian market has risen 1.7%, driven by gains of 12% in the Materials sector, although the Financials sector is down 3.2%. Over the past 12 months, the market is up 17%, with earnings forecast to grow by 12% annually. In this context, identifying undervalued small-cap stocks with insider buying can be a strategic move for investors looking to capitalize on potential growth opportunities within a robust market environment.
Simply Wall St.3 Undervalued Small Caps In Australia With Insider Action
In the last week, the Australian market has stayed flat, with notable gains of 9.0% in the Materials sector. Over the past year, the market is up 16%, and earnings are forecast to grow by 12% annually. In this context, identifying undervalued small-cap stocks with insider action can offer promising opportunities for investors looking to capitalize on potential growth within a stable market environment.
